-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VYFpoPYRJy6IigyLTFfXvuEpuLK61DhvEt3eXBj2oPJZF41bxslMy+BLmwSgKzqb Ehg9oNZNLYxqJjxzuqradw== 0000950134-05-002612.txt : 20050210 0000950134-05-002612.hdr.sgml : 20050210 20050210170822 ACCESSION NUMBER: 0000950134-05-002612 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050210 DATE AS OF CHANGE: 20050210 GROUP MEMBERS: ANSBERT GADICKE GROUP MEMBERS: LUKE EVNIN GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS 2001 LLC GROUP MEMBERS: MPM BIOVENTURES GMBH & CO PARALLEL-BETEILIGUNGS KG GROUP MEMBERS: MPM BIOVENTURES II-QP LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EYETECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001115285 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134104684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80385 FILM NUMBER: 05593949 BUSINESS ADDRESS: STREET 1: 3 TIMES SQUARE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 2128243100 MAIL ADDRESS: STREET 1: 3 TIMES SQUARE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MPM BIOVENTURES II LP CENTRAL INDEX KEY: 0001264829 IRS NUMBER: 043523685 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE STREET 2: 31ST FL CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6174259200 SC 13G 1 f05654sc13g.htm SCHEDULE 13G sc13g
Table of Contents

OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

EYETECH PHARMACEUTICALS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

302297 10 6

(CUSIP Number)

December 31, 2004

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        o Rule 13d-1 (b)

        o Rule 13d-1 (c)

        þ Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
MPM BioVentures II, L.P.		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Delaware
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
75,926
6. Shared Voting Power:
0
7. Sole Dispositive Power:
75,926
8.Shared Dispositive Power:
0
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
725,926
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
0.2%
  12.Type of Reporting Person:
PN

Page 2 of 12

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
MPM BioVentures II-QP, L.P.		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Delaware
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
688,033
6. Shared Voting Power:
0
7. Sole Dispositive Power:
688,033
8.Shared Dispositive Power:
0
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
688,033
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
1.7%
  12.Type of Reporting Person:
PN

Page 3 of 12

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Germany
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
242,270
6. Shared Voting Power:
0
7. Sole Dispositive Power:
242,270
8.Shared Dispositive Power:
0
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
242,270
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
0.6%
  12.Type of Reporting Person:
PN

Page 4 of 12

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
MPM Asset Management Investors 2001 LLC		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
Delaware
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
14,287
6. Shared Voting Power:
0
7. Sole Dispositive Power:
14,287
8.Shared Dispositive Power:
0
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
14,287
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
0.0%
  12.Type of Reporting Person:
OO

Page 5 of 12

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
Ansbert Gadicke		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
0
6. Shared Voting Power:
1,020,516*
7. Sole Dispositive Power:
0
8.Shared Dispositive Power:
1,020,516*
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
1,020,516*
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
2.5%
  12.Type of Reporting Person:
IN

* The shares are held as follows: 75,926 shares by MPM BioVentures II, L.P. ("BV II"), 688,033 shares by MPM BioVentures II-QP, L.P. ("BV QP"), 242,270 shares by MPM BioVentures GmbH & Co. Parallel Beteiligungs KG ("BV KG") and 14,287 shares MPM Asset Management Investors 2001 LLC ("AM LLC"). MPM Asset Management II LP ("AM II LP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II, BV QP and BV KG. The Reporting Person is a member of AM II LLC and AM LLC.

Page 6 of 12

Table of Contents

             
13G
CUSIP No. 302297 10 6
  1. Name of Reporting Person:
Luke Evnin		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) þ  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
0
6. Shared Voting Power:
1,020,516*
7. Sole Dispositive Power:
0
8.Shared Dispositive Power:
1,020,516*
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
1,020,516*
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
2.5%
  12.Type of Reporting Person:
IN

* The shares are held as follows: 75,926 shares by MPM BioVentures II, L.P. ("BV II"), 688,033 shares by MPM BioVentures II-QP, L.P. ("BV QP"), 242,270 shares by MPM BioVentures GmbH & Co. Parallel Beteiligungs KG ("BV KG") and 14,287 shares MPM Asset Management Investors 2001 LLC ("AM LLC"). MPM Asset Management II LP ("AM II LP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II, BV QP and BV KG. The Reporting Person is a member of AM II LLC and AM LLC.

Page 7 of 12

TABLE OF CONTENTS

Item 1.
Item 2.
Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Item 4. Ownership
Item 5. Ownership of Five Percent or Less of a Class
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of a Group
Item 10. Certification
SIGNATURE

Table of Contents

Item 1.   

  (a)   Name of Issuer
Eyetech Pharmaceuticals, Inc.

  (b)   Address of Issuer’s Principal Executive Offices
500 Seventh Avenue, 18th Floor
New York, NY 10018

Item 2.   

  (a)   Name of Person Filing

MPM BioVentures II, LP
MPM BioVentures II-QP, L.P.
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
MPM Asset Management Investors 2001 LLC
Ansbert Gadicke
Luke Evnin

  (b)   Address of Principal Business Office or, if none, Residence

c/o MPM Capital L.P.
111 Huntington Avenue, 31st floor
Boston, MA 02199

  (c)   Citizenship

All entities were organized in Delaware, except MPM BioVentures GmbH & Co Parallel-Beteiligungs KG which was organized in Germany. The individuals are United States citizens.

  (d)   Title of Class of Securities

Common Stock

  (e)   CUSIP Number

302297 10 6

Item 3.  If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Item 4.  Ownership

  (a)   Amount Beneficially Owned:

           
MPM BioVentures II, LP
       75,926  
MPM BioVentures II-QP, L.P.
       688,033  
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       242,270  
MPM Asset Management Investors 2001 LLC
       14,287  
Ansbert Gadicke
       1,020,516 *
Luke Evnin
       1,020,516 *

Page 8 of 12

Table of Contents

Percent of Class:

           
MPM BioVentures II, LP
       0.2 %
MPM BioVentures II-QP, L.P.
       1.7 %
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       .6 %
MPM Asset Management Investors 2001 LLC
       0.0 %
Ansbert Gadicke
       2.5 %
Luke Evnin
       2.5 %

  (b)   Number of shares as to which the person has:

  (i)   Sole power to vote or to direct the vote

           
MPM BioVentures II, LP
       75,926  
MPM BioVentures II-QP, L.P.
       688,033  
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       242,270  
MPM Asset Management Investors 2001 LLC
       14,287  
Ansbert Gadicke
       0  
Luke Evnin
       0  

  (ii)   Shared power to vote or to direct the vote

           
MPM BioVentures II, LP
       0  
MPM BioVentures II-QP, L.P.
       0  
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       0  
MPM Asset Management Investors2001 LLC
       0  
Ansbert Gadicke
       1,020,516 *
Luke Evnin
       1,020,516 *

  (iii)   Sole power to dispose or to direct the disposition of

           
MPM BioVentures II, LP
       75,926  
MPM BioVentures II-QP, L.P.
       688,033  
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       242,270  
MPM Asset Management Investors 2001 LLC
       14,287  
Ansbert Gadicke
       0  
Luke Evnin
       0  

  (iv)   Shared power to dispose or to direct the disposition of

           
MPM BioVentures II, LP
       0  
MPM BioVentures II-QP, L.P.
       0  
MPM BioVentures GmbH & Co Parallel-Beteiligungs KG
       0  
MPM Asset Management Investors 2001 LLC
       0  
Ansbert Gadicke
       1,020,516 *

Page 9 of 12

Table of Contents

           
Luke Evnin
       1,020,516 *

* The shares are held as follows: 75,926 shares by MPM BioVentures II, L.P. (“BV II”), 688,033 shares by MPM BioVentures II-QP, L.P. (“BV QP”), 242,270 shares by MPM BioVentures GmbH & Co. Parallel Beteiligungs KG (“BV KG”) and 14,287 shares MPM Asset Management Investors 2001 LLC (“AM LLC”). MPM Asset Management II LP (“AM II LP”) and MPM Asset Management II LLC (“AM II LLC”) are the direct and indirect general partners of BV II, BV QP and BV KG. The Reporting Person is a member of AM II LLC and AM LLC.

Item 5.  Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ý.

Item 6.  Ownership of More than Five Percent on Behalf of Another Person

     Not Applicable

Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     Not Applicable

Item 8.  Identification and Classification of Members of the Group

     Not Applicable

Item 9.  Notice of Dissolution of a Group

     Not Applicable

Item 10.  Certification

     Not Applicable

Page 10 of 12

Table of Contents

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 9, 2005

             
MPM BIOVENTURES II, L.P.       MPM BIOVENTURES II-QP, L.P.
 
            
By:
   MPM Asset Management II, L.P.,
its General Partner		   By:   MPM Asset Management II, L.P.,
its General Partner
 
            
By:
   MPM Asset Management II LLC,
its General Partner		   By:   MPM Asset Management II LLC,
its General Partner
 
            
By:
  
/s/ Luke B. Evnin
   By:  
/s/ Luke B. Evnin
 
            
 
   Name: Luke B. Evnin       Name: Luke B. Evnin
 
   Title: Manager       Title: Manager
 
            
 
            
MPM CAPITAL GMBH. & CO.        
PARALLEL-BETEILIGUNGS KG       MPM ASSET MANAGEMENT INVESTORS 2001
        LLC
By:
   MPM Asset Management II LP, in its        
capacity as the Special Limited Partner
   By:  
/s/ Luke B. Evnin
 
            
        Name: Luke B. Evnin
            Title: Manager
By:
   MPM Asset Management II LLC, its        
General Partner
        
 
            
By:
  
/s/ Luke B. Evnin
        
 
            
 
   Name: Luke B. Evnin        
 
   Title: Manager        
 
            
 
            
 
            
By:
  
/s/ Ansbert Gadicke
   By:  
/s/ Luke B. Evnin
 
            
 
   Name: Ansbert Gadicke       Name: Luke B. Evnin

Page 11 of 12

Table of Contents

EXHIBIT A

JOINT FILING AGREEMENT

     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Eyetech Pharmaceuticals, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 9th day of February, 2005.

             
MPM BIOVENTURES II, L.P.       MPM BIOVENTURES II-QP, L.P.
 
            
By:
   MPM Asset Management II, L.P.,
its General Partner		   By:   MPM Asset Management II, L.P.,
its General Partner
 
            
By:
   MPM Asset Management II LLC,
its General Partner		   By:   MPM Asset Management II LLC,
its General Partner
 
            
By:
  
/s/ Luke B. Evnin
   By:  
/s/ Luke B. Evnin
 
            
 
   Name: Luke B. Evnin       Name: Luke B. Evnin
 
   Title: Manager       Title: Manager
 
            
 
            
MPM CAPITAL GMBH. & CO.        
PARALLEL-BETEILIGUNGS KG       MPM ASSET MANAGEMENT INVESTORS 2001
        LLC
By:
   MPM Asset Management II LP, in its        
capacity as the Special Limited Partner
   By:  
/s/ Luke B. Evnin
 
            
        Name: Luke B. Evnin
            Title: Manager
By:
   MPM Asset Management II LLC, its        
General Partner
        
 
            
By:
  
/s/ Luke B. Evnin
        
 
            
 
   Name: Luke B. Evnin        
 
   Title: Manager        
 
            
 
            
 
            
By:
  
/s/ Ansbert Gadicke
   By:  
/s/ Luke B. Evnin
 
            
 
   Name: Ansbert Gadicke       Name: Luke B. Evnin

Page 12 of 12

-----END PRIVACY-ENHANCED MESSAGE-----